Table 7.
The cytotoxic activities of glycosides 1–5, cisplatin and chitonoidoside A (positive controls) against human erythrocytes, HeLa, DLD-1 and HL-60 human cell lines.
| Glycosides | ED50, µM, Erythrocytes | Cytotoxicity, ED50 µM | ||
|---|---|---|---|---|
| HeLa | DLD-1 | HL-60 | ||
| Chitonoidoside I (1) | 1.26 ± 0.09 | 20.56 ± 1.06 | 69.12 ± 5.12 | 17.50 ± 0.95 |
| Chitonoidoside J (2) | 2.48 ± 0.13 | 17.64 ± 0.70 | 58.17 ± 4.27 | 10.17 ± 0.89 |
| Chitonoidoside K (3) | 0.29 ± 0.01 | 13.82 ± 1.10 | 9.20 ± 0.21 | 6.77 ± 0.44 |
| Chitonoidoside K1 (4) | >100.00 | >100.00 | >100.00 | >100.00 |
| Chitonoidoside L (5) | 0.71 ± 0.03 | 15.21 ± 1.45 | 16.45 ± 0.51 | 7.89 ± 0.44 |
| Chitonoidoside A | 7.51 ± 0.11 | 45.36 ± 1.05 | 39.67 ± 1.36 | 12.83 ± 0.87 |
| Cisplatin | - | 23.82 ± 1.81 | >100.00 | 6.77 ± 0.14 |